Webinar: How Pharma is using Fresh Human Tissues to Better Predict Drug Safety and Efficacy

 

How Pharma is Using Human Fresh Tissues to Better Predict Drug Safety and Efficacy (full)

 

About the Speaker

REPROCELL-04.06.18_0852

David Bunton is co-founder and CEO of Biopta Ltd. After graduating from the University of Glasgow with an Honours degree in Physiology, he undertook a PhD in Pharmacology at Glasgow Caledonian University, which led immediately to his appointment as a Lecturer in Physiology and Pharmacology.

David was also a consultant to the Diabetes Education and Training Unit at Glasgow Caledonian and has numerous publications in respiratory and vascular pharmacology, including a number of reviews on the state of the art in human tissue research. He is a member of the British Pharmacological Society and Safety Pharmacology Society, and is an active contributor to the drive towards greater use of human tissues in drug development having co-organised the 2009 human tissue conference at the House of Lords. Email: davidbunton@reprocell.com.